Occupational Allergic Rhinitis: What Do We Know?

被引:0
|
作者
Mungan D. [1 ]
机构
[1] Department of Pulmonary Diseases, Division of Allergy and Immunology, School of Medicine, Ankara University, Ankara
关键词
Occupational allergy; Occupational asthma; Occupational rhinitis; Rhinitis; Work related rhinitis;
D O I
10.1007/s40521-014-0041-x
中图分类号
学科分类号
摘要
• The main objectives of the management of occupational rhinitis are, elimination of symptoms and prevention of development of asthma. • Management strategies include, environmental interventions (cessation or reducing the exposure to the causal agent) and appropriate pharmacologic treatment. • Drug therapy does not differ from non-occupational rhinitis. • Given the increased risk for occupational asthma in patients with occupational rhinitis, the most effective approach is complete avoidance of exposure to the offending agent. However, if complete cessation of exposure leads to adverse socio-economic measures, reduction in contact with the agent in combination with drug therapy can be considered. • Allergen immunotherapy (AIT) has been used for a few sensitizers in occupational allergic diseases. The use of AIT is very limited due to inadequate standardization of occupational allergens. Effective treatment of patients with occupational allergy by the use of AIT may allow workers to continue their work when exposure can not be avoided. The new technologies are expected to improve the quality and efficacy of specific immunotherapy in patients with occupational allergy in the future. © 2014, Springer International Publishing AG.
引用
收藏
页码:10 / 19
页数:9
相关论文
共 50 条
  • [31] Zebrafish and steroids: What do we know and what do we need to know?
    Tokarz, Janina
    Moeller, Gabriele
    de Angelis, Martin Hrabe
    Adamski, Jerzy
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 : 165 - 173
  • [32] Managing dyspepsia: What do we know and what do we need to know?
    Rabeneck, L
    Wray, NP
    Graham, DY
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (06): : 920 - 924
  • [33] Fear of falling: What do we know, what do we need to know?
    Lach, HW
    GERONTOLOGIST, 2001, 41 : 387 - 387
  • [34] ECONOMIC NETWORKS: WHAT DO WE KNOW AND WHAT DO WE NEED TO KNOW?
    Schweitzer, Frank
    Fagiolo, Giorgio
    Sornette, Didier
    Vega-Redondo, Fernando
    White, Douglas R.
    ADVANCES IN COMPLEX SYSTEMS, 2009, 12 (4-5): : 407 - 422
  • [35] Dietary interventions for AMD: what do we know and what do we not know?
    Evans, Jennifer R.
    Lawrenson, John G.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (09) : 1089 - 1090
  • [36] Pediatric stroke: What do we know and what do we need to know?
    Lynch, JK
    Han, CJ
    SEMINARS IN NEUROLOGY, 2005, 25 (04) : 410 - 423
  • [37] DO WE KNOW WHAT WE DONT KNOW
    LITTLE, B
    JOURNAL OF PRODUCT INNOVATION MANAGEMENT, 1985, 2 (01) : 1 - 2
  • [38] How do we know what we know?
    Hug, Joa
    FILOSOFICKY CASOPIS, 2015, 63 (01): : 150 - 153
  • [39] HOW DO WE KNOW WHAT WE KNOW?
    Manton, Anne
    JOURNAL OF EMERGENCY NURSING, 2015, 41 (05) : 372 - 372
  • [40] Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next?
    Kaplowitz, N
    HEPATOLOGY, 2004, 40 (01) : 23 - 26